Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
78.69
+0.71 (0.91%)
Dec 31, 2025, 2:11 PM EST - Market open
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.14 billion as of December 31, 2025. Its market cap has increased by 422.88% in one year.
Market Cap
1.14B
Enterprise Value
1.09B
1-Year Change
422.88%
Ranking
Category
Stock Price
$78.69
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.14B, an increase of 477.31%. That is a compound annual growth rate of 201.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 1.15B | 417.15% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.26B |
| Johnson & Johnson | 498.77B |
| AbbVie | 405.39B |
| UnitedHealth Group | 301.73B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 263.14B |
| Novo Nordisk | 229.27B |